Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience

BACKGROUND AND OBJECTIVE: Here, we present real-world data on the incidence and risk factors of acute exacerbation (AE) in patients with chronic fibrotic interstitial pneumonia (CFIP) treated with antifibrotic agents, which has been previously poorly documented. METHODS: We retrospectively examined...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Pulm Med
Main Authors: Kawamura, Kodai, Ichikado, Kazuya, Ichiyasu, Hidenori, Anan, Keisuke, Yasuda, Yuko, Suga, Moritaka, Sakagami, Takuro
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6593518/
https://ncbi.nlm.nih.gov/pubmed/31238929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0880-0
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki